139344-15-3

Upstream product

• 139230-90-3 (1R,2S,3R,4S)-3-Methoxymethoxymethyl-bicyclo[2.2.1]hept-5-ene-2-carboxylic acid 
• 139230-92-5 (+)-(1S,4R)-5-endo-(4-chlorobenzenesulphonylamino)-6-endo-<(methoxymethoxy)methyl>bicyclo<2.2.1>hept-2-ene 
• 139256-84-1 (1R,2S,3R,4S)-3-Methoxymethoxymethyl-bicyclo[2.2.1]hept-5-en-2-ylamine 
• 131694-93-4 (-)-methyl (1R,4S)-3-endo-<(methoxymethoxy)methyl>bicyclo<2.2.1>hept-5-ene-2-endo-carboxylate 
• 131726-11-9 (2,S)-endo-methoxycarbonyl-(3,R)-endo-hydroxymethylbicyclo<2.2.1>heptene-5 

Downstream Products

• 139230-93-6 (Z)-6-[(1S,2R,3S,4R)-3-(4-Chloro-benzenesulfonylamino)-bicyclo[2.2.1]hept-5-en-2-yl]-hex-5-enoic acid methyl ester 
• 139230-93-6 (E)-6-[(1S,2R,3S,4R)-3-(4-Chloro-benzenesulfonylamino)-bicyclo[2.2.1]hept-5-en-2-yl]-hex-5-enoic acid methyl ester 

Relevant academic research and scientific papers

Novel Route to Some Biologically Important Compounds Starting with a Common Chiral, Bicyclic, Fused Lactone: Enantioselective Synthesis of (-)-Boschnialactone and Two Antithrombotics

Three biologically important compounds, (-)-boschnialactone and the antithrombotics (+)- and (-)-(5Z)-6-hept-5-en-2-endo- and exo-yl>hex-5-enoic acid have been synthesized starting from a common